Marco Gobbi Selected Research

meso- tetrakis(1- methyl- 4- pyridiniumyl)porphyrin

3/2016

A cationic tetrapyrrole inhibits toxic activities of the cellular prion protein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco Gobbi Research Topics

Disease

22	Neoplasms (Cancer) 01/2022 - 04/2002
20	Alzheimer Disease (Alzheimer's Disease) 09/2019 - 03/2009
11	Multiple Myeloma 12/2020 - 02/2002
11	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019 - 01/2006
10	Lymphoma (Lymphomas) 01/2022 - 03/2007
10	Leukemia 10/2020 - 01/2003
9	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2021 - 11/2004
8	Prion Diseases (Transmissible Spongiform Encephalopathies) 10/2021 - 01/2006
7	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2019 - 02/2003
7	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019 - 02/2004
6	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 10/2005
6	Infections 01/2021 - 02/2003
6	Hematologic Neoplasms (Hematological Malignancy) 10/2020 - 06/2009
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2014 - 10/2005
4	COVID-19 05/2022 - 01/2021
4	Heart Arrest (Cardiac Arrest) 12/2021 - 08/2014
4	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2013 - 10/2003
3	Residual Neoplasm 11/2021 - 11/2012
3	Amyloidosis 01/2021 - 09/2013
3	Brain Injuries (Brain Injury) 12/2020 - 09/2012
3	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 02/2014 - 01/2006
3	Disease Progression 01/2013 - 04/2002
3	Anemia 11/2011 - 02/2004
3	Seizures (Absence Seizure) 06/2008 - 02/2005
2	Fatal Familial Insomnia 10/2021 - 09/2013
2	Reperfusion Injury 01/2021 - 03/2016
2	Polyneuropathies (Polyneuropathy) 01/2021 - 06/2007
2	Brain Ischemia (Cerebral Ischemia) 01/2021 - 09/2012
2	Breast Neoplasms (Breast Cancer) 01/2021 - 07/2012
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020 - 01/2014
2	Neuroinflammatory Diseases 01/2019 - 10/2018
2	Gliosis 01/2019 - 03/2017
2	Hairy Cell Leukemia 01/2018 - 11/2009
2	Genomic Instability 03/2016 - 01/2015
2	Cognitive Dysfunction 10/2014 - 02/2010
2	Inflammation (Inflammations) 08/2014 - 04/2010
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2014 - 07/2004
2	Transthyretin-Related Hereditary Amyloidosis 09/2013 - 06/2012
2	Pain (Aches) 09/2013 - 01/2008

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2002
14	Amyloid (Amyloid Fibrils)IBA 10/2018 - 01/2006
11	Peptides (Polypeptides)IBA 01/2017 - 04/2010
10	fludarabineIBA 01/2019 - 02/2003
9	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020 - 11/2004
8	Pharmaceutical PreparationsIBA 05/2022 - 06/2008
8	Doxycycline (Periostat)FDA LinkGeneric 10/2021 - 06/2012
8	Rituximab (Mabthera)FDA Link 01/2020 - 07/2004
6	Prion ProteinsIBA 10/2021 - 01/2006
6	NAD (NADH)IBA 01/2018 - 01/2011
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2010
5	CytokinesIBA 01/2014 - 07/2004
5	Imatinib Mesylate (Gleevec)FDA Link 04/2011 - 01/2006
4	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 01/2021 - 09/2012
4	Dexamethasone (Maxidex)FDA LinkGeneric 12/2020 - 01/2018
4	Bortezomib (Velcade)FDA Link 12/2020 - 08/2013
4	Tyrosine Kinase InhibitorsIBA 10/2020 - 10/2015
4	Bendamustine Hydrochloride FDA Link 10/2019 - 09/2011
4	AntibodiesIBA 01/2019 - 06/2007
4	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2018 - 11/2004
4	LigandsIBA 03/2017 - 08/2011
4	Etoposide (VP 16)FDA LinkGeneric 11/2014 - 10/2005
4	Biological ProductsIBA 09/2013 - 08/2012
4	Erythropoietin FDA Link 06/2013 - 02/2004
4	Amyloid beta-PeptidesIBA 07/2012 - 03/2009
3	Antiviral Agents (Antivirals)IBA 05/2022 - 01/2021
3	KynurenineIBA 12/2021 - 08/2014
3	Complement System Proteins (Complement)IBA 01/2020 - 07/2011
3	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2019 - 11/2008
3	PrionsIBA 01/2019 - 02/2014
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2018 - 10/2007
3	nilotinib FDA Link 01/2018 - 02/2008
3	Nicotinamide PhosphoribosyltransferaseIBA 12/2016 - 08/2013
3	Melphalan (Alkeran)FDA LinkGeneric 11/2014 - 10/2005
3	Valproic Acid (Depakote)FDA LinkGeneric 02/2012 - 08/2009
3	Mitoxantrone (Novantrone)FDA LinkGeneric 04/2008 - 07/2004
2	VaccinesIBA 05/2022 - 05/2020
2	Neuroprotective AgentsIBA 01/2021 - 12/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 04/2002
2	Infliximab (Remicade)FDA Link 01/2021 - 01/2019
2	Thalidomide (Thalomid)FDA Link 12/2020 - 04/2002
2	Phosphotransferases (Kinase)IBA 10/2020 - 02/2010
2	ibrutinibIBA 10/2020 - 12/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2015
2	Protein Isoforms (Isoforms)IBA 01/2017 - 03/2016
2	Histone Deacetylases (Histone Deacetylase)IBA 03/2016 - 01/2011
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2015 - 10/2014
2	N- (4- (1- benzoylpiperidin- 4- yl)butyl)- 3- (pyridin- 3- yl)acrylamideIBA 09/2015 - 06/2009
2	Ranolazine FDA Link 10/2014 - 09/2014
2	InterferonsIBA 01/2014 - 02/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014 - 02/2003
2	EpitopesIBA 09/2013 - 01/2003
2	Azacitidine (5 Azacytidine)FDA Link 06/2013 - 08/2009
2	Vorinostat FDA Link 01/2013 - 01/2011

Therapy/Procedure

29	Therapeutics 01/2021 - 04/2002
6	Drug Therapy (Chemotherapy) 12/2018 - 02/2002
5	Stem Cell Transplantation 11/2021 - 04/2002
4	Transplantation 01/2020 - 01/2008
3	Salvage Therapy 10/2005 - 04/2002
2	Cardiopulmonary Resuscitation (CPR) 12/2020 - 09/2014
2	Retreatment 01/2020 - 01/2018